#FECMM
@efisg-escmid.bsky.social Chair 2024-26
YoungEHA Committee member 2025-
@fungiscope.bsky.social #VACCELERATE #EPICOVIDEHA
#hematology #mycoses #ViralRespiratoryInfections
www.clinicalsurveys.net/uc/EFISG_web...
2025
18/11, +@ESGAP_ABS Antifungal stewardship
11–12/12, XII Mycological Forum🇪🇸
16/12, Dermatophytes dx and tx
17/12, Dengue in hem/onc
22/12, IDWeek and CHEST hightlights
2026
20/01, Taxonomy
17/01, Point-of-care dx
www.clinicalsurveys.net/uc/EFISG_web...
2025
18/11, +@ESGAP_ABS Antifungal stewardship
11–12/12, XII Mycological Forum🇪🇸
16/12, Dermatophytes dx and tx
17/12, Dengue in hem/onc
22/12, IDWeek and CHEST hightlights
2026
20/01, Taxonomy
17/01, Point-of-care dx
Still looking for cases of viral respiratory infections 🦠 of any kind within #EPICOVIDEHA / #EPIRESEHA 🧬
Always a pleasure to exchange ideas with our Italian colleagues! 🇮🇹
Still looking for cases of viral respiratory infections 🦠 of any kind within #EPICOVIDEHA / #EPIRESEHA 🧬
Always a pleasure to exchange ideas with our Italian colleagues! 🇮🇹
Findings show critical inequities in access to mycology labs, antifungal drugs, and @who.int-recommended diagnostics.
Full study 👉 www.sciencedirect.com/science/arti...
Findings show critical inequities in access to mycology labs, antifungal drugs, and @who.int-recommended diagnostics.
Full study 👉 www.sciencedirect.com/science/arti...
Catch the latest EPICOVIDEHA-EPIRESEHA webinar on influenza, RSV, hMPV and more:
youtu.be/C2LTcEDnAoI?...
Catch the latest EPICOVIDEHA-EPIRESEHA webinar on influenza, RSV, hMPV and more:
youtu.be/C2LTcEDnAoI?...
Mon, Oct 27 (from 15:45, poster area)
🧬P1301 – Respiratory viruses in hem/onc
🦠P1303 – hMPV vs Influenza vs SARS-CoV-2
🧫P1304 – RSV vs Influenza vs SARS-CoV-2
🇵🇪P1305 – IFI dx and tx capacity - Peru
🇭🇳P1306– IFI dx and tx capacity - Honduras
Mon, Oct 27 (from 15:45, poster area)
🧬P1301 – Respiratory viruses in hem/onc
🦠P1303 – hMPV vs Influenza vs SARS-CoV-2
🧫P1304 – RSV vs Influenza vs SARS-CoV-2
🇵🇪P1305 – IFI dx and tx capacity - Peru
🇭🇳P1306– IFI dx and tx capacity - Honduras
🕚 11:00 (S/T rooms) – Ceftazidim-avibactam in action
🕕 18:55 (Poster area) – Antifungal stewardship spotlight
@dgho_ev
🕚 11:00 (S/T rooms) – Ceftazidim-avibactam in action
🕕 18:55 (Poster area) – Antifungal stewardship spotlight
@dgho_ev
🗓️ Sat, 25 Oct | 17:45 | Postehalle
🦟 P416 #Dengue in hem/onc
🍄 P417 #Mucorales experience
💊 P418 #ISAV introduction
🧫 P419 #Aspergillus experience
🗓️ Sat, 25 Oct | 17:45 | Postehalle
🦟 P416 #Dengue in hem/onc
🍄 P417 #Mucorales experience
💊 P418 #ISAV introduction
🧫 P419 #Aspergillus experience
In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%).
Low EQUAL #Candida Scores predicted persistence
💡 Adherence saves lives
🔗 www.journalofinfection.com/article/S016...
In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%).
Low EQUAL #Candida Scores predicted persistence
💡 Adherence saves lives
🔗 www.journalofinfection.com/article/S016...
Revisit to the 2024 ATS recommendations on:
1️⃣ Combination therapy for IPA
2️⃣ Empirical/prophylactic treatment for IC in ICU
👉 www.sciencedirect.com/science/arti...
Revisit to the 2024 ATS recommendations on:
1️⃣ Combination therapy for IPA
2️⃣ Empirical/prophylactic treatment for IC in ICU
👉 www.sciencedirect.com/science/arti...
@salmantongarcia.bsky.social, wants to extend an invitation for all of us to join the webinars courtesy of @efisg-escmid.bsky.social
We are so glad to share this information and the QR codes for you to join to each of the following meetings
@salmantongarcia.bsky.social, wants to extend an invitation for all of us to join the webinars courtesy of @efisg-escmid.bsky.social
We are so glad to share this information and the QR codes for you to join to each of the following meetings
📅 Oct 22, 2025 | 16:00 CET | #EPIRESEHA: Insights and perspectives on viral #respiratory_infections
F. Marchesi, IT – #Influenza
J. Salmanton-García, DE – #RSV
M. Biernat, PL – #hMPV
B. Weinbergerova, CZ – #Other_viruses
uni-koeln.zoom.us/meeting/register/r0LvqJ95QNWZuYhJXbUAIg
📅 Oct 22, 2025 | 16:00 CET | #EPIRESEHA: Insights and perspectives on viral #respiratory_infections
F. Marchesi, IT – #Influenza
J. Salmanton-García, DE – #RSV
M. Biernat, PL – #hMPV
B. Weinbergerova, CZ – #Other_viruses
uni-koeln.zoom.us/meeting/register/r0LvqJ95QNWZuYhJXbUAIg
#Fluco-R #Candida_parapsilosis is a growing threat in hospitals.
In a #multicenter matched cohort study, #echinocandins and #LAmB showed comparable outcomes for bloodstream infections
journals.asm.org/doi/epub/10....
@escmid.bsky.social @taescmid.bsky.social
#Fluco-R #Candida_parapsilosis is a growing threat in hospitals.
In a #multicenter matched cohort study, #echinocandins and #LAmB showed comparable outcomes for bloodstream infections
journals.asm.org/doi/epub/10....
@escmid.bsky.social @taescmid.bsky.social
| In Spanish | with EFISG | @salmantongarcia.bsky.social on site 📸
| In Spanish | with EFISG | @salmantongarcia.bsky.social on site 📸
🦠 Explore #RSV, #influenza, #hMPV and more in hematology with experts
@olivercornely.bsky.social @salmantongarcia.bsky.social
Register 👉 uni-koeln.zoom.us/meeting/regi...
🦠 Explore #RSV, #influenza, #hMPV and more in hematology with experts
@olivercornely.bsky.social @salmantongarcia.bsky.social
Register 👉 uni-koeln.zoom.us/meeting/regi...
🔬 @BioMedCentral #Immunology is inviting submissions for our Collection on #Fungal Infections!
📅 Deadline: 26 June 2026
🌍 Topics:
Fungal pathogenesis
Immune responses
Antifungals
Precision medicine
& more...
👉 Submit here: www.biomedcentral.com/collections/...
🔬 @BioMedCentral #Immunology is inviting submissions for our Collection on #Fungal Infections!
📅 Deadline: 26 June 2026
🌍 Topics:
Fungal pathogenesis
Immune responses
Antifungals
Precision medicine
& more...
👉 Submit here: www.biomedcentral.com/collections/...
Over half the world is still waiting… and people are dying. Let’s act now.
Over half the world is still waiting… and people are dying. Let’s act now.
💉 Weekly echinocandin in invasive candidiasis/candidemia
🏥 15 pts | 4 countries
✅ Feasible for outpatients
💪 Active vs resistant #Candida
🛑 Access + admin barriers
👉 Real-world insights!
onlinelibrary.wiley.com/doi/epdf/10....
💉 Weekly echinocandin in invasive candidiasis/candidemia
🏥 15 pts | 4 countries
✅ Feasible for outpatients
💪 Active vs resistant #Candida
🛑 Access + admin barriers
👉 Real-world insights!
onlinelibrary.wiley.com/doi/epdf/10....
Submit your work to #Infections in #Hematology:
Advances in
#Diagnosis
#Management
#Prevention
#Patient_care
🗓️ Manuscript summary: 15 Dec 2025
🗓️ Full submission: 4 Apr 2026
🔗 frontiersin.org/research-top...
@frontiersin.bsky.social
Submit your work to #Infections in #Hematology:
Advances in
#Diagnosis
#Management
#Prevention
#Patient_care
🗓️ Manuscript summary: 15 Dec 2025
🗓️ Full submission: 4 Apr 2026
🔗 frontiersin.org/research-top...
@frontiersin.bsky.social
✅ 100% sensitivity + specificity for vaginal swabs
✅ Faster + field-friendly (days → minutes)
✅ Promising tool for low-resource settings
www.sciencedirect.com/science/arti...
✅ 100% sensitivity + specificity for vaginal swabs
✅ Faster + field-friendly (days → minutes)
✅ Promising tool for low-resource settings
www.sciencedirect.com/science/arti...
✅ High acceptance among #ESP transplant teams
✅ 127 HIV+ organs discarded in '98–'19 could be used
✅ #ESP legalized HIV+ donation in '25
www.clinicalmicrobiologyandinfection.org/article/S119...
@seimc.bsky.social
✅ High acceptance among #ESP transplant teams
✅ 127 HIV+ organs discarded in '98–'19 could be used
✅ #ESP legalized HIV+ donation in '25
www.clinicalmicrobiologyandinfection.org/article/S119...
@seimc.bsky.social